KA
AGN

Kaizen Advisory’s Allergan plc AGN Stock Holding History

Kaizen Advisory’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$113K Buy
848
+18
+2% +$2.95K 0.08% 210
2018
Q3 		$158K Hold
830
– – 0.08% 179
2018
Q2 		$138K Buy
830
+506
+156% +$81.2K 0.07% 194
2018
Q1 		$55K Hold
324
– – 0.05% 190
2017
Q4 		$53K Buy
+324
New +$58.1K 0.03% 187

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Kaizen Advisory's AGN Position: Q4 2018 in Review

Kaizen Advisory increased its Allergan plc (AGN) stake by 2.2% in Q4 2018, buying an estimated $2.95K and bringing the position to 848 shares worth $113K. The position accounts for 0.08% of the portfolio, ranked #210.

Kaizen Advisory first reported a position in AGN in Q4 2017 and has held it in 5 quarters since. The position peaked at $158K in Q3 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Kaizen Advisory held 848 shares of Allergan plc worth $113K as of Q4 2018.
  • Kaizen Advisory bought 18 Allergan plc shares in Q4 2018, an estimated $2.95K.
  • Allergan plc made up 0.08% of Kaizen Advisory's portfolio in Q4 2018, its #210 holding.
  • Kaizen Advisory first reported a position in Allergan plc in Q4 2017 and has held it in 5 quarters since.
  • Kaizen Advisory's Allergan plc position peaked at $158K in Q3 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Kaizen Advisory's 13F filing for Q4 2018, filed 15 Feb 2019.